MAIA Biotechnology, Inc. Shares Outstanding (Cover Page)
MAIA Biotechnology, Inc. (MAIA) had Shares Outstanding (Cover Page) of 60.83 million shares as of 2026-08-10, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10
- 2026-08-10: Entity Common Stock, Shares Outstanding 60.83M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 60.80M shares.
- 2026-03-23: Entity Common Stock, Shares Outstanding 60.67M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 37.03M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 60.83M shares 10-Q · filed 2026-08-10 |
| 2026-05-11 | 60.80M shares 10-Q · filed 2026-05-11 |
| 2026-03-23 | 60.67M shares 10-K · filed 2026-03-23 |
| 2025-11-07 | 37.03M shares 10-Q · filed 2025-11-07 |
| 2025-08-11 | 32.99M shares 10-Q · filed 2025-08-11 |
| 2025-05-09 | 30.31M shares 10-Q · filed 2025-05-09 |
| 2025-03-21 | 29.59M shares 10-K · filed 2025-03-21 |
| 2024-11-12 | 25.33M shares 10-Q · filed 2024-11-12 |
| 2024-08-09 | 23.91M shares 10-Q · filed 2024-08-09 |
| 2024-05-14 | 21.84M shares 10-Q · filed 2024-05-14 |
| 2024-03-21 | 20.00M shares 10-K · filed 2024-03-21 |
| 2023-11-07 | 14.21M shares 10-Q · filed 2023-11-07 |
| 2023-08-08 | 13.63M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 13.63M shares 10-Q · filed 2023-05-08 |
| 2023-03-22 | 11.00M shares 10-K · filed 2023-03-24 |
| 2022-11-08 | 10.95M shares 10-Q/A · filed 2023-02-06 |
| 2022-08-18 | 10.94M shares 10-Q · filed 2022-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |